SWM
MYOV

SeaCrest Wealth Management’s Myovant Sciences Ltd. MYOV Stock Holding History

SeaCrest Wealth Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,050
Closed -$25K – 1621
2022
Q2 		$25K Buy
+2,050
New +$22.6K ﹤0.01% 1415

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SeaCrest Wealth Management's MYOV Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 2,050 shares — an estimated $25K sold.

SeaCrest Wealth Management first reported a position in MYOV in Q2 2022 and held it in 1 quarter. The position peaked at $25K in Q2 2022. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 2,050 Myovant Sciences Ltd. shares in Q3 2022, an estimated $25K.
  • SeaCrest Wealth Management first reported a position in Myovant Sciences Ltd. in Q2 2022 and held it in 1 quarter.
  • SeaCrest Wealth Management's Myovant Sciences Ltd. position peaked at $25K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.